Patient variability in the pharmacokinetics of itraconazole supports quantitative monitoring of blood drug levels, particularly due to its variable absorption. Monitoring trough levels of intraconazole and hydroxyitraconazole (the metabolite of intraconazole) is suggested in the first 1 - 2 weeks of treatment to ensure therapeutic levels have been achieved. Results may be clinically useful to determine if current dosing levels require adjustment for ongoing treatment.
About Immunosuppressive Drug Level Monitoring
The successful management of transplant rejection and graft vs. host disease (GVHD) continues to pose a difficult challenge for physicians treating solid organ and bone marrow transplant patients. Immunosuppressive drugs are commonly used to prevent rejection in these patient populations. Compliance with immunosuppressive therapy is essential to long term survival, however provides the additional risks of infection. Therapeutic drug monitoring of immunosuppressive medication is required due to variable metabolism, absorption and drug interactions. By using drug level monitoring with timely results, the physician is able to individualize drug dosage to improve efficacy and reduce toxicity.
Itraconazole/hydroxyitraconazole are extracted from biological matrix by simple protein precipitation with methanol followed by centrifugation. Chromatographic separation and quantitative analysis of the drug containing supernatant is performed using reversed-phase UPLC-MS/MS method. This test has not been cleared or approved for diagnostic use by the U.S. Food and Drug Administration.
Same day (within 8 - 12 hours from receipt of specimen), Monday through Saturday.
|Specimen Type||Order Code||CPT Code||NY Approved||Volume||Assay Range||Special Instructions|
|plasma||2801||80299||Yes||1 mL (min. 0.5 mL)||0.1-10 mcg/mL||
|serum||2810||80299||Yes||1 mL (min. 0.5 mL)||0.1-10 mcg/mL||
Ship Monday through Friday. Friday shipments must be labeled for Saturday delivery. All specimens must be labeled with patient's name and collection date. A Viracor Eurofins test requisition form must accompany each specimen. Multiple tests can be run on one specimen. Ship specimens FedEx Priority Overnight® to: Viracor Eurofins, 1001 NW Technology Dr, Lee's Summit, MO 64086.
Specimens received not frozen, whole blood collected in serum or plasma gel, serum gel tubes, or specimen types other than those listed are not accepted.
Specimens are approved for testing in New York only when indicated in the Specimen Information field above.
The CPT codes provided are based on Viracor Eurofins' interpretation of the American Medical Association's Current Procedural Terminology (CPT) codes and are provided for general informational purposes only. CPT coding is the sole responsibility of the billing party. Questions regarding coding should be addressed to your local Medicare carrier. Viracor Eurofins assumes no responsibility for billing errors due to reliance on the CPT codes illustrated in this material.